Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”
In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires
PCI Files Application For Research Base COP
Eight applications Received For NSABP chairman
Pitt Criticizes NCI Stance On Repayment For Fraud Trials
Broder, Herberman, Decline To Coauthor Reanalysis of Data
“I Can’t Permit Destruction of NSABP,” Fisher Writes
Herberman: Progress Made To Stabilize NSABP
Trending Stories
- Rachna Shroff, accomplished GI oncologist and “tireless mentor,” dies at 47
Her endowed award will live on - Kevan Shokat made KRAS druggable. With daraxonrasib now in the clinic, he is “all in” on the ultimate target: p53
Shokat was named 2026 Stephenson Global Prize winner - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Iowa’s “cancer crisis” emerges as a top issue on the campaign trail
- California’s Prop 38 is an historic approach to funding medical research, immunology
The $8.4B bond makes a long-term investment in a field with life-saving power - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma
